SELF STUDY / ENDURING - ESTIMATED TIME TO COMPLETE ACTIVITY: 120 Minutes

Overview

Chronic rhinosinusitis with nasal polyps (CRSwNP) is a chronic condition that negatively impacts the quality of life. The introduction of biologics in CRSwNP management represents a transformative shift in the treatment landscape, yet several practical challenges persist. The expanding array of treatment options adds complexity to the treatment selection processes. The intricate interplay of disease and patient factors, along with socioeconomic metrics, underscores the crucial role of shared decision-making to personalize treatment approaches. This educational initiative utilizes Horizon CME’s innovative DynamicGapEdTM platform powered by PlayPosit. Through a highly interactive format with numerous clinical questions, the initiative aims to assess learner knowledge, competence, and performance in the diagnosis and management of CRSwNP.

Learning Objectives

1. Assess results from recent clinical trials and real-world evidence studies of emerging therapeutic strategies for chronic rhinosinusitis with nasal polyps (CRSwNP) and how biologics fit into the treatment landscape
2. Identify emerging response biomarkers to biologics and their potential role in guiding treatment decisions of CRSwNP
3. Implement monitoring parameters and management strategies for adverse events associated with biologics in patients with CRSwNP
4. Apply effective strategies to optimize treatment of CRSwNP

Target Audience

The primary audience is otolaryngologists (MD/DO) and mid-level providers who specialize in otolaryngology including nurse practitioners (NP) and physician assistants (PA). The secondary audience is Allergists and Pulmonologists, Internal Medicine, Primary Care and Rural providers.

This activity is supported by an independent medical education grant from Regeneron Pharmaceuticals, Inc and Sanofi.